References
- Carceller A., Blanchard H., Champhagne J., St-Vil D., Bensoussan A. L. Surgical resection and chemotherapy improve survival rate for patients with hepatoblastoma. J Pediatr Surg, 2001 ; 36: 755–759.
- King D. R., Ortega J., Campbell J., Haas J., Ablin A., Lloyd D., Newman K., Quinn J., Krailo M., Feusner J., Hammond D. The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy. J Pediatr Surg, 1991, 26: 1074–1081.
- Reynolds M., Douglass E. C., Finegold M., Cantor A B., Glicksman A. Chemotherapy can convert unresectable hepatoblastoma. J Pediatr Surg, 1992, 27: 1080–1084.
- Douglass E. C., Reynolds M., Finegold M., Cantor A. B., Glicksman A. Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: A Pediatric Oncology Group Study. J Clin Oncol, 1993, 11: 96–99.
- Evans A. E., Land V. J., Newton W. A., Randolph J. G., Sather H. N., Tefft M. Combination chemotherapy (vincristine, Adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer, 1982, 50: 821–826.
- Ortega J., Krailo M. D., Haas J. E., King D. R., Ablin A. R., Quinn J. J., Feusner J., Campbell J. R., Lloyd D. A., Cherlow J., Hammond G. D. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continous infusion doxorubicin chemotherapy: A report from the Childrens Cancer Study Group. J Clin Oncol, 1991, 9: 2167–2176.
- Von Schweinitz D., Hecker H., Harms D., Bode U., Weinel P., Bürger D., Erttmann R., Mildenberger H. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma-A report from the German Cooperative Pediatric Liver Tumour Study HB-89. J Pediatr Surg, 1995, 30: 845–852.
- Ehrlich P.F., Greenberg M.L., Filler R.M. Improved long-term survival with pre-operative chemotherapy for hepatoblastoma. J Pediatr Surg, 1997, 32: 999–1003.
- Pierro A., Langevin A. M., Filler R. M., Liu P., Philips M. J., Greenberg M. L. Pre-operative chemotherapy in ‘unresectable’ hepatoblastoma. J Pediatr Surg, 1989, 24: 24–29.
- Van Tornout J. M., Buckley J. D., Quinn J. J., Feusner J. H., Krailo M. D., King D. R., Hammond G. D., Ortega J. A. Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: A report from the Childrens Cancer Group. J Clin Oncol, 1997, 15: 1190–1197.
- Boechat M. I., Kangarloo H., Ortega J., Hall T., Feig S., Stanley P., Gilsanz V. Primary liver tumours in children: Comparison of CT and MR imaging. Radiology, 1988, 169: 727732.
- Stringer M. D., Hennayake S., Howard E. R., Spitz L., Shafford E. A., Mieli-Vergani G., Saxena R., Malone M., Dicks-Mireaux C., Karani J., Mowat A. P., Pritchard J. Improved outcome for children with hepatoblastoma. Br J Surg, 1995, 82: 386–391.
- Weinberg A. G., Finegold M. J. Primary hepatic tumours of childhood. Hum Pathol, 1983, 14 (6): 512–537.
- Tagge E. P., Tagge D. U., Reyes J., Tzakis A., Iwatsuki S., Starzl T. E., Wiener E. S. Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: Impact on survival. J Pediatr Surg, 1992, 27: 2 92–297.
- Reyes G. Results of liver transplantation in children with unresectable liver tumours. J Pediatr Surg, 1996, 31: 835–839.